Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Kidney Neoplasms 3Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urogenital Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, Non-Hodgkin 1Gliosarcoma 1Glioblastoma 1Carcinoma, Squamous Cell 1Carcinoma, Large Cell 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

Radiotherapy 54Temozolomide 50Filgrastim 25Cyclophosphamide 25Etoposide 24Cisplatin 22Carboplatin 22Vincristine 19Chemotherapy, Adjuvant 18Peripheral Blood Stem Cell Transplantation 15Thiotepa 13Carmustine 12Thalidomide 10Methotrexate 9Magnetic Resonance Spectroscopy 9Irinotecan 9Bevacizumab 9Granulocyte Colony-Stimulating Factor 7sargramostim 6Topotecan 6Lomustine 6X-Rays 5Tamoxifen 5Specimen Handling 5Phantoms, Imaging 5O(6)-benzylguanine 5Ifosfamide 5Erlotinib Hydrochloride 5Drug Therapy 5Celecoxib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Central Nervous System Neoplasms × motexafin gadolinium × Clear all
NCT00514397 2013-08-12

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
43 enrolled
CNS

Central Nervous System Neoplasms

NCT00022256 2013-06-18

Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡